Generating Symmetry in the Asymmetric ATP-binding Cassette (ABC) Transporter Pdr5 from Saccharomyces cerevisiae*
- From the Institute of Biochemistry, Heinrich Heine University Düsseldorf, Universitätsstrasse 1, 40225 Düsseldorf, Germany
- ↵1 To whom correspondence should be addressed. Tel.: 49-211-81-10773; Fax: 49-211-81-15310; E-mail: lutz.schmitt{at}hhu.de.
Abstract
Pdr5 is a plasma membrane-bound ABC transporter from Saccharomyces cerevisiae and is involved in the phenomenon of resistance against xenobiotics, which are clinically relevant in bacteria, fungi, and humans. Many fungal ABC transporters such as Pdr5 display an inherent asymmetry in their nucleotide-binding sites (NBS) unlike most of their human counterparts. This degeneracy of the NBSs is very intriguing and needs explanation in terms of structural and functional relevance. In this study, we mutated nonconsensus amino acid residues in the NBSs to its consensus counterpart and studied its effect on the function of the protein and effect on yeast cells. The completely “regenerated” Pdr5 protein was severely impaired in its function of ATP hydrolysis and of rhodamine 6G transport. Moreover, we observe alternative compensatory mechanisms to counteract drug toxicity in some of the mutants. In essence, we describe here the first attempts to restore complete symmetry in an asymmetric ABC transporter and to study its effects, which might be relevant to the entire class of asymmetric ABC transporters.
- ABC Transporter
- ATPases
- Membrane Proteins
- Membrane Transport
- Multidrug Transporters
- Coupling Mechanism
Footnotes
-
↵* This work was supported by Deutsche Forschungsgemeinschaft Grant Schm1279/5-3 and European Drug Initiative on Channels and Transporters FP7 Theme Health-2007–2.1.1.-5 (to L. S.).
- Received January 27, 2014.
- Revision received March 24, 2014.
- © 2014 by The American Society for Biochemistry and Molecular Biology, Inc.











